Effects of 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol in dogs with impaired renal function.
Dzanis
D A
DA
Department of Clinical Sciences, New York State College of Veterinary Medicine, Cornell University, Ithaca 14853.
Corbellini
C N
CN
Krook
L
L
Kallfelz
F A
FA
D015650:24,25-Dihydroxyvitamin D 3 / Q000009:adverse effects / Q000627:therapeutic use*; D000818:Animals; D001066:Appetite / Q000187:drug effects; D001284:Atrophy; D001835:Body Weight / Q000187:drug effects; D001842:Bone and Bones / Q000473:pathology; D002117:Calcitriol / Q000009:adverse effects / Q000627:therapeutic use*; D004285:Dogs; D005260:Female; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology; D007674:Kidney Diseases / Q000188:drug therapy*; D010280:Parathyroid Glands / Q000473:pathology
D015650:24,25-Dihydroxyvitamin D 3; D002117:Calcitriol